CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 86 enrolled
Drug / intervention
Nitroglycerin and lidocaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01155167
NCT01155167Phase 3Completed
CompareCT.gov

The Effect of Topical Administration of Lidocaine/Nitroglycerin Combination Versus Placebo on Radial Artery Access in Patients Undergoing Cardiac Catheterization Via the Radial Artery

University of California, San Francisco·interventional·Posted Jul 1, 2010·Updated Sep 25, 2018

In Brief

A Phase 3 clinical trial evaluating Nitroglycerin and lidocaine and Placebo for Cardiac Catheterization and Spasm. Completed, enrolled 86 participants across 1 site.

Detailed Summary

The aim of the study is to facilitate radial artery access for cardiac catheterization. The investigators hypothesize that topical nitroglycerin and lidocaine will reduce radial artery spasm. Patients undergoing cardiac catheterization via the radial artery will be randomized to topical nitroglycerin + lidocaine versus placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Catheterization, Spasm
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 1, 2010
Enrollment StartJul 1, 2010
Primary CompletionAug 1, 2011
Study CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 16.0 years ago

Interventions

Nitroglycerin and lidocainedrug

Topical Nitroglycerin and lidocaine

Placeboother

Placebo